IP Verse

Methods And Materials For Assessing Homologous Recombination Deficiency - EP2981624

The patent EP2981624 was granted to Abkevich on Dec 18, 2019. The application was originally filed on Apr 4, 2014 under application number EP14779403A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2981624

ABKEVICH
Application Number
EP14779403A
Filing Date
Apr 4, 2014
Status
Opposition Rejected
Feb 17, 2023
Grant Date
Dec 18, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SIEMENS HEALTHCARESep 15, 2020ADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONWO2011160063
OPPOSITIONWO2012027224
SEARCHKR100925337B
SEARCHWO2011160063
SEARCHWO2012027224
SEARCHWO2013130347

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- ABKEVICH, A. et al., "Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer", British Journal of Cancer, (20121009), vol. 107, doi:10.1038/bjc.2012.451, pages 1776 - 1782, XP055085758
OPPOSITION- POPOVA, T. et al., "Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA1/2 Inactivation", Cancer Res, (20120829), vol. 72, no. 21, doi:10.1158/0008-5472.CAN-12-1470, pages 5454 - 5462, XP055341888
OPPOSITION- BIRBAK, N.J. et al., "Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents", Cancer Discovery, (20120322), vol. 2, doi:10.1158/2159-8290.CD-11-0206, pages 366 - 375, XP055162779
SEARCH[XPYI] - Anonymous, "Myriad's HRD Test Significantly Predicts Response to Cisplatin Treatment in Patients With Triple Negative Breast Cancer in Second Research Study", (20131214), Myriad, URL: http://files.shareholder.com/downloads/MYGN/3039924177x0x713818/74F0EC3E-B337-4724-A51B-63BA3BD75A08/MYGN_News_2013_12_14_General.pdf, (20161019), XP055312045 [XP] 1,7,10 * the whole document * [Y] 2,11,12 [I] 3-6,8,9,13-15-
SEARCH- MARIEKE A VOLLEBERGH ET AL, "Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers", CMLS CELLULAR AND MOLECULAR LIFE SCIENCES, BIRKHĂ„USER-VERLAG, BA, (20110916), vol. 69, no. 2, doi:10.1007/S00018-011-0809-0, ISSN 1420-9071, pages 223 - 245, XP019993251 [A] 1-15 * the whole document *
SEARCH- V ABKEVICH ET AL, "Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer", BRITISH JOURNAL OF CANCER, (20121106), vol. 107, no. 10, doi:10.1038/bjc.2012.451, ISSN 0007-0920, pages 1776 - 1782, XP055085758 [AD] 1-15 * the whole document *
SEARCH- T. POPOVA ET AL, "Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation", CANCER RESEARCH, (20120829), doi:10.1158/0008-5472.CAN-12-1470, ISSN 0008-5472, XP055039519 [YD] 2,11,12 * abstract; p. 4, 1st para.; p. 21, 1st para. *
SEARCH- Ml Telli ET AL, "Abstract PD09-04: Homologous Recombination Deficiency (HRD) score predicts pathologic response following neoadjuvant platinum-based therapy in triple-negative and BRCA1/2 mutation-associated breast cancer (BC)", Cancer Research, (20121215), URL: http://cancerres.aacrjournals.org/content/72/24_Supplement/PD09-04, (20161019), XP055312264 [AD] 1-15 * the whole document *
SEARCH- N. J. BIRKBAK ET AL, "Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents", CANCER DISCOVERY, (20120322), vol. 2, no. 4, doi:10.1158/2159-8290.CD-11-0206, ISSN 2159-8274, pages 366 - 375, XP055162779 [A] 1-15 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents